JP2024517793A5 - - Google Patents
Info
- Publication number
- JP2024517793A5 JP2024517793A5 JP2023567114A JP2023567114A JP2024517793A5 JP 2024517793 A5 JP2024517793 A5 JP 2024517793A5 JP 2023567114 A JP2023567114 A JP 2023567114A JP 2023567114 A JP2023567114 A JP 2023567114A JP 2024517793 A5 JP2024517793 A5 JP 2024517793A5
- Authority
- JP
- Japan
- Prior art keywords
- lymphocytes
- tumor
- population
- cells
- antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21171565.1 | 2021-04-30 | ||
| EP21171565 | 2021-04-30 | ||
| PCT/EP2022/061639 WO2022229464A1 (en) | 2021-04-30 | 2022-04-29 | Single vessel expansion of lymphocytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517793A JP2024517793A (ja) | 2024-04-23 |
| JP2024517793A5 true JP2024517793A5 (https=) | 2025-06-20 |
Family
ID=76034406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567114A Pending JP2024517793A (ja) | 2021-04-30 | 2022-04-29 | 単一容器リンパ球拡大 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240287454A1 (https=) |
| EP (1) | EP4330380A1 (https=) |
| JP (1) | JP2024517793A (https=) |
| KR (1) | KR20240026905A (https=) |
| CN (1) | CN117321189A (https=) |
| AU (1) | AU2022267777A1 (https=) |
| BR (1) | BR112023022485A2 (https=) |
| CA (1) | CA3214450A1 (https=) |
| MX (1) | MX2023012698A (https=) |
| WO (1) | WO2022229464A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115558641B (zh) * | 2022-11-14 | 2023-05-12 | 四川新生命干细胞科技股份有限公司 | 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用 |
| WO2024261339A1 (en) | 2023-06-23 | 2024-12-26 | Tigen Pharma Sa | Lymphocyte-stimulatory matrix (lsm) and uses thereof for expansion of lymphocyte populations |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5350674A (en) | 1992-09-04 | 1994-09-27 | Becton, Dickinson And Company | Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof |
| CU23734A1 (es) | 2009-11-27 | 2011-11-15 | Centro Inmunologia Molecular | Polipéptidos inmunomoduladores derivados de la il-2 con actividad antagonista de esta citocina útiles en la terapia del cáncer y enfermedades infecciosas crónicas |
| EP2569633B1 (en) | 2010-05-14 | 2016-02-10 | The General Hospital Corporation | Compositions and methods of identifying tumor specific neoantigens |
| EP2983702A2 (en) | 2013-04-07 | 2016-02-17 | The Broad Institute, Inc. | Compositions and methods for personalized neoplasia vaccines |
| US20160310584A1 (en) | 2013-12-06 | 2016-10-27 | The Broad Institute Inc. | Formulations for neoplasia vaccines |
| KR20230076867A (ko) | 2013-12-20 | 2023-05-31 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신생항원 백신과의 병용 요법 |
| EP3234130B1 (en) | 2014-12-19 | 2020-11-25 | The Broad Institute, Inc. | Methods for profiling the t-cell- receptor repertoire |
| IL294183B2 (en) | 2015-05-20 | 2023-10-01 | Dana Farber Cancer Inst Inc | shared neoantigens |
| EP3323070B1 (en) | 2015-07-14 | 2024-05-08 | Personal Genome Diagnostics Inc. | Neoantigen analysis |
| ES2970865T3 (es) | 2015-12-16 | 2024-05-31 | Gritstone Bio Inc | Identificación, fabricación y uso de neoantígenos |
| CA3034452A1 (en) | 2016-08-21 | 2018-03-01 | Adva Biotechnology Ltd. | Bioreactor and methods of use thereof |
| WO2018213803A1 (en) | 2017-05-19 | 2018-11-22 | Neon Therapeutics, Inc. | Immunogenic neoantigen identification |
| EP3707245A1 (en) * | 2017-11-06 | 2020-09-16 | Ludwig Institute for Cancer Research Ltd | Method for expansion of lymphocytes |
| US20230052157A1 (en) | 2019-12-12 | 2023-02-16 | Achilles Therapeutics Uk Limited | Method for obtaining nucleic acid for sequencing |
| JP2023510950A (ja) | 2020-01-20 | 2023-03-15 | アドヴァ バイオテクノロジー リミテッド | バイオリアクタを制御する装置及び方法 |
-
2022
- 2022-04-29 JP JP2023567114A patent/JP2024517793A/ja active Pending
- 2022-04-29 WO PCT/EP2022/061639 patent/WO2022229464A1/en not_active Ceased
- 2022-04-29 CA CA3214450A patent/CA3214450A1/en active Pending
- 2022-04-29 KR KR1020237041122A patent/KR20240026905A/ko active Pending
- 2022-04-29 EP EP22727052.7A patent/EP4330380A1/en active Pending
- 2022-04-29 AU AU2022267777A patent/AU2022267777A1/en not_active Abandoned
- 2022-04-29 MX MX2023012698A patent/MX2023012698A/es unknown
- 2022-04-29 US US18/288,893 patent/US20240287454A1/en active Pending
- 2022-04-29 CN CN202280031807.4A patent/CN117321189A/zh active Pending
- 2022-04-29 BR BR112023022485A patent/BR112023022485A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230399615A1 (en) | Icos critically regulates the expansion and function of inflammatory human th17 cells | |
| JP6114768B2 (ja) | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 | |
| JP4762887B2 (ja) | 付加的なサイトカインの非存在下でｇｍ−ｃｓｆを用いる単球樹状前駆細胞からの樹状細胞の産生 | |
| JP2019531744A5 (https=) | ||
| CN102575231B (zh) | 制备细胞因子诱导的杀伤细胞的方法 | |
| CN107636150A (zh) | 半静态细胞培养 | |
| AU2008303453B2 (en) | An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases | |
| CN110381989A (zh) | 用于免疫细胞操作的抗原呈递支架 | |
| EP1666589B1 (en) | Process for producing cytotoxic lymphocytes | |
| CN102027104A (zh) | 含有细胞因子诱导杀伤细胞的细胞群的制造方法 | |
| CN1353575A (zh) | 用树状细胞一肿瘤细胞或树状细胞一病毒细胞衍生的免疫原在体外诱导抗原特异性t－销细胞 | |
| JP2024517793A5 (https=) | ||
| CN1446583A (zh) | 一种肿瘤免疫治疗及预防性疫苗的组成、制备、应用方案 | |
| EP1537203B1 (en) | USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) | |
| JP2025541604A (ja) | リンパ球の拡大 | |
| CN115996732A (zh) | 人专职性抗原提呈细胞的制造方法 | |
| Pineda et al. | Antigen presentation requirements for effective cDC1-based cancer immunotherapy | |
| US20040072140A1 (en) | Dehydrated antigen presenting cells usable for vaccination | |
| CN120249400A (zh) | 一种基因工程载体、肿瘤趋化性工程细胞及其在实体瘤中的应用 | |
| HK1170533B (en) | Process for production of cytokine-induced killer cells | |
| HK1079989B (en) | Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response |